- Recorded a strong performance with sales of Rs. 267.8 crores, up 4% vs a year ago.
- The Profit After Tax (PAT) was Rs. 55.4 crores against Rs. 59.3 crores a year ago.
Milind Thatte, Managing Director, Procter & Gamble Health Limited said, “We delivered a strong performance in our first quarter of fiscal 2022 focused on executing our strategies of offering superior brands, driving productivity, increasing reach, and improving awareness. With the country gradually easing restrictions further due to improved vaccination coverage, we will continue our strategy to leverage technology and deliver constructive disruption to better serve our consumers and customers who count on our brands and the benefits they provide.”